|
EIF4A3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.146810E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.448000E-01 |
| Normal-vs-Stage2 |
9.755000E-01 |
| Normal-vs-Stage3 |
1.557230E-01 |
| Normal-vs-Stage4 |
4.955500E-02 |
| Stage1-vs-Stage2 |
6.256800E-01 |
| Stage1-vs-Stage3 |
2.680800E-01 |
| Stage1-vs-Stage4 |
7.001800E-02 |
| Stage2-vs-Stage3 |
2.374400E-01 |
| Stage2-vs-Stage4 |
5.347900E-02 |
| Stage3-vs-Stage4 |
1.504440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.849800E-02 |
| Normal-vs-AfricanAmerican |
6.274400E-01 |
| Normal-vs-Asian |
4.588600E-01 |
| Caucasian-vs-AfricanAmerican |
1.623760E-01 |
| Caucasian-vs-Asian |
6.400200E-01 |
| AfricanAmerican-vs-Asian |
5.099800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.375200E-01 |
| Normal-vs-Female |
4.102000E-03 |
| Male-vs-Female |
4.538100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.861400E-01 |
| Normal-vs-Extreme_Weight |
2.786000E-01 |
| Normal-vs-Obese |
1.528370E-01 |
| Normal-vs-Extreme_Obese |
7.405600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.759600E-01 |
| Normal_Weight-vs-Obese |
6.274800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.350000E-01 |
| Extreme_Weight-vs-Obese |
6.745200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.036800E-01 |
| Obese-vs-Extreme_Obese |
2.885600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.084800E-03 |
| Normal-vs-Age(41-60Yrs) |
5.844200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.762600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.435400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.041000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.516500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.420030E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.588100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.908400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.870600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.028600E-01 |
| Normal-VS-Type2 PRCC |
9.692600E-01 |
| Normal-VS-KIRP CIMP |
1.217020E-03 |
| Normal-VS-Unclassified PRCC |
4.852400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.156100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.722400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.833000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.40259999673142E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
4.836200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.924150E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.918400E-01 |
| Normal-vs-N1 |
6.639500E-03 |
| Normal-vs-N2 |
2.668800E-01 |
| N0-vs-N1 |
2.637500E-03 |
| N0-vs-N2 |
2.478400E-01 |
| N1-vs-N2 |
5.195200E-01 |
|
|
